XML 37 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair value measurements (Tables)
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Financial Instruments Measured At Fair Value On A Recurring Basis
Financial instruments measured at fair value on a recurring basis, by valuation hierarchy
June 30, 2017
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
2,486

 
$
650

 
$

 
$
3,136

Foreign

 
21,625

 
85

 
21,710

Corporate securities

 
24,617

 
747

 
25,364

Mortgage-backed securities

 
14,428

 
45

 
14,473

States, municipalities, and political subdivisions

 
16,962

 

 
16,962

 
2,486

 
78,282

 
877

 
81,645

Equity securities
817

 

 
39

 
856

Short-term investments
1,421

 
1,223

 
7

 
2,651

Other investments (1)
430

 
282

 
243

 
955

Securities lending collateral

 
1,545

 

 
1,545

Investment derivative instruments
12

 

 

 
12

Other derivative instruments
9

 

 

 
9

Separate account assets
2,147

 
101

 

 
2,248

Total assets measured at fair value (1)
$
7,322

 
$
81,433

 
$
1,166

 
$
89,921

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
35

 
$

 
$

 
$
35

Other derivative instruments

 

 
2

 
2

GLB (2)

 

 
357

 
357

Total liabilities measured at fair value
$
35

 
$

 
$
359

 
$
394

(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $3,711 million and other investments of $19 million at June 30, 2017 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
 
December 31, 2016
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
2,175

 
$
695

 
$

 
$
2,870

Foreign

 
21,366

 
74

 
21,440

Corporate securities

 
23,468

 
681

 
24,149

Mortgage-backed securities

 
13,962

 
45

 
14,007

States, municipalities, and political subdivisions

 
17,649

 

 
17,649

 
2,175

 
77,140

 
800

 
80,115

Equity securities
773

 

 
41

 
814

Short-term investments
1,757

 
1,220

 
25

 
3,002

Other investments (1)
384

 
259

 
225

 
868

Securities lending collateral

 
1,092

 

 
1,092

Investment derivative instruments
31

 

 

 
31

Other derivative instruments
3

 

 

 
3

Separate account assets
1,784

 
95

 

 
1,879

Total assets measured at fair value (1)
$
6,907

 
$
79,806

 
$
1,091

 
$
87,804

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
54

 
$

 
$

 
$
54

Other derivative instruments

 

 
13

 
13

GLB (2)

 

 
559

 
559

Total liabilities measured at fair value
$
54

 
$

 
$
572

 
$
626


(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $3,626 million and other investments of $25 million at December 31, 2016 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
Fair Value And Maximum Future Funding Commitments Related To Investments
The following table presents, by investment category, the expected liquidation period, fair value, and maximum future funding commitments of alternative investments:
 
 
 
 
 
June 30

 
 
 
December 31

 
Expected
Liquidation
Period of Underlying Assets
 
 
 
2017

 
 
 
2016

(in millions of U.S. dollars)
Fair
Value

 
Maximum
Future Funding
Commitments

 
Fair
Value

 
Maximum
Future Funding
Commitments

Financial
5 to 9 Years
 
$
576

 
$
354

 
$
548

 
$
428

Real Assets
3 to 7 Years
 
622

 
181

 
536

 
230

Distressed
5 to 9 Years
 
350

 
175

 
485

 
179

Private Credit
3 to 7 Years
 
238

 
337

 
236

 
259

Traditional
3 to 9 Years
 
1,646

 
805

 
1,550

 
930

Vintage
1 to 2 Years
 
19

 

 
21

 
14

Investment funds
Not Applicable
 
260

 

 
251

 

 
 
 
$
3,711

 
$
1,852

 
$
3,627

 
$
2,040

Schedule Of Significant Unobservable Inputs Used In Level 3 Liability Valuations
The following table presents the significant unobservable inputs used in the Level 3 liability valuations. Excluded from the table below are inputs used to determine the fair value of Level 3 assets which are based on single broker quotes and contain no quantitative unobservable inputs developed by management.
(in millions of U.S. dollars, except for percentages)
Fair Value
 
 
Valuation
Technique
 
Significant
Unobservable Inputs
 
Ranges
June 30, 2017

 
December 31, 2016

 
 
 
GLB (1)
$
357

 
$
559

 
Actuarial model
 
Lapse rate
 
3% – 34%
 
 
 
 
 
 
 
Annuitization rate
 
0% – 78%
(1) 
Discussion of the most significant inputs used in the fair value measurement of GLB and the sensitivity of those assumptions is included within Note 4 a) Guaranteed living benefits.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

Short-term investments

Other
investments

 
Other
derivative
instruments

GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
80

 
$
737

 
$
45

 
$
41

$
21

$
233

 
$
11

$
466

Transfers into Level 3

 
28

 

 



 

9

Transfers out of Level 3

 
(13
)
 

 



 
(9
)

Change in Net Unrealized Gains (Losses) included in OCI
3

 

 

 
1


(1
)
 


Net Realized Gains/Losses
2

 

 

 



 

(118
)
Purchases
19

 
65

 

 
6

7

16

 


Sales
(19
)
 
(28
)
 

 
(9
)


 


Settlements

 
(42
)
 

 

(21
)
(5
)
 


Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

$
7

$
243

 
$
2

$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

$

$

 
$

$
(118
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $774 million at March 31, 2017, which includes a fair value derivative adjustment of $357 million and $466 million, respectively.

  
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

Short-term investments

Other
investments

 
Other derivative instruments

GLB(1)

June 30, 2016
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
62

 
$
261

 
$
48

 
$
29

$

$
211

 
$
10

$
839

Transfers into Level 3
3

 
2

 

 



 


Change in Net Unrealized Gains (Losses) included in OCI
3

 
9

 

 
(1
)


 


Net Realized Gains/Losses
(1
)
 
(2
)
 

 
1



 

132

Purchases
27

 
31

 
1

 
10

50

8

 


Sales
(7
)
 
(16
)
 

 
(2
)


 


Settlements

 
(4
)
 

 


(3
)
 


Balance – end of period
$
87

 
$
281

 
$
49

 
$
37

$
50

$
216

 
$
10

$
971

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(1
)
 
$

 
$

 
$

$

$

 
$

$
132

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $1.3 billion at June 30, 2016, and $1.1 billion at March 31, 2016, which includes a fair value derivative adjustment of $971 million and $839 million, respectively.

 
Assets
 
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
Equity
securities

Short-term investments

Other
investments

 
Other
derivative
instruments

GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
74

 
$
681

 
$
45

 
$
41

$
25

$
225

 
$
13

$
559

Transfers into Level 3

 
57

 

 



 

9

Transfers out of Level 3

 
(67
)
 

 



 
(9
)

Change in Net Unrealized Gains (Losses) included in OCI
2

 
(8
)
 

 
1


3

 


Net Realized Gains/Losses
1

 
(1
)
 

 



 
(2
)
(211
)
Purchases
33

 
221

 
1

 
6

14

24

 


Sales
(22
)
 
(55
)
 
(1
)
 
(9
)


 


Settlements
(3
)
 
(81
)
 

 

(32
)
(9
)
 


Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

$
7

$
243

 
$
2

$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

$

$

 
$
(2
)
$
(211
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $853 million at December 31, 2016, which includes a fair value derivative adjustment of $357 million and $559 million, respectively.

  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB(1)

June 30, 2016
Foreign

 
Corporate
securities

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
57

 
$
174

 
$
53

 
$
16

 
$

 
$
212

 
$
6

 
$
609

Transfers into Level 3
9

 
18

 

 

 

 

 

 

Transfers out of Level 3
(2
)
 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI
9

 
11

 

 
(1
)
 

 

 

 

Net Realized Gains/Losses
(6
)
 
(8
)
 

 
1

 

 

 
2

 
362

Purchases (2)
32

 
124

 
1

 
23

 
50

 
14

 
2

 

Sales
(8
)
 
(30
)
 
(5
)
 
(2
)
 

 

 

 

Settlements
(4
)
 
(8
)
 

 

 

 
(10
)
 

 

Balance – end of period
$
87

 
$
281

 
$
49

 
$
37

 
$
50

 
$
216

 
$
10

 
$
971

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(5
)
 
$
(7
)
 
$

 
$

 
$

 
$

 
$
2

 
$
362

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $1.3 billion at June 30, 2016, and $888 million at December 31, 2015, which includes a fair value derivative adjustment of $971 million and $609 million, respectively.
(2) 
Includes acquired invested assets as a result of the Chubb Corp acquisition.

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

Short-term investments

Other
investments

 
Other
derivative
instruments

GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
80

 
$
737

 
$
45

 
$
41

$
21

$
233

 
$
11

$
466

Transfers into Level 3

 
28

 

 



 

9

Transfers out of Level 3

 
(13
)
 

 



 
(9
)

Change in Net Unrealized Gains (Losses) included in OCI
3

 

 

 
1


(1
)
 


Net Realized Gains/Losses
2

 

 

 



 

(118
)
Purchases
19

 
65

 

 
6

7

16

 


Sales
(19
)
 
(28
)
 

 
(9
)


 


Settlements

 
(42
)
 

 

(21
)
(5
)
 


Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

$
7

$
243

 
$
2

$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

$

$

 
$

$
(118
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $774 million at March 31, 2017, which includes a fair value derivative adjustment of $357 million and $466 million, respectively.

  
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

Short-term investments

Other
investments

 
Other derivative instruments

GLB(1)

June 30, 2016
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
62

 
$
261

 
$
48

 
$
29

$

$
211

 
$
10

$
839

Transfers into Level 3
3

 
2

 

 



 


Change in Net Unrealized Gains (Losses) included in OCI
3

 
9

 

 
(1
)


 


Net Realized Gains/Losses
(1
)
 
(2
)
 

 
1



 

132

Purchases
27

 
31

 
1

 
10

50

8

 


Sales
(7
)
 
(16
)
 

 
(2
)


 


Settlements

 
(4
)
 

 


(3
)
 


Balance – end of period
$
87

 
$
281

 
$
49

 
$
37

$
50

$
216

 
$
10

$
971

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(1
)
 
$

 
$

 
$

$

$

 
$

$
132

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $1.3 billion at June 30, 2016, and $1.1 billion at March 31, 2016, which includes a fair value derivative adjustment of $971 million and $839 million, respectively.

 
Assets
 
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
Equity
securities

Short-term investments

Other
investments

 
Other
derivative
instruments

GLB(1)

June 30, 2017
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
74

 
$
681

 
$
45

 
$
41

$
25

$
225

 
$
13

$
559

Transfers into Level 3

 
57

 

 



 

9

Transfers out of Level 3

 
(67
)
 

 



 
(9
)

Change in Net Unrealized Gains (Losses) included in OCI
2

 
(8
)
 

 
1


3

 


Net Realized Gains/Losses
1

 
(1
)
 

 



 
(2
)
(211
)
Purchases
33

 
221

 
1

 
6

14

24

 


Sales
(22
)
 
(55
)
 
(1
)
 
(9
)


 


Settlements
(3
)
 
(81
)
 

 

(32
)
(9
)
 


Balance – end of period
$
85

 
$
747

 
$
45

 
$
39

$
7

$
243

 
$
2

$
357

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$

$

$

 
$
(2
)
$
(211
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $684 million at June 30, 2017, and $853 million at December 31, 2016, which includes a fair value derivative adjustment of $357 million and $559 million, respectively.

  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB(1)

June 30, 2016
Foreign

 
Corporate
securities

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
57

 
$
174

 
$
53

 
$
16

 
$

 
$
212

 
$
6

 
$
609

Transfers into Level 3
9

 
18

 

 

 

 

 

 

Transfers out of Level 3
(2
)
 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI
9

 
11

 

 
(1
)
 

 

 

 

Net Realized Gains/Losses
(6
)
 
(8
)
 

 
1

 

 

 
2

 
362

Purchases (2)
32

 
124

 
1

 
23

 
50

 
14

 
2

 

Sales
(8
)
 
(30
)
 
(5
)
 
(2
)
 

 

 

 

Settlements
(4
)
 
(8
)
 

 

 

 
(10
)
 

 

Balance – end of period
$
87

 
$
281

 
$
49

 
$
37

 
$
50

 
$
216

 
$
10

 
$
971

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(5
)
 
$
(7
)
 
$

 
$

 
$

 
$

 
$
2

 
$
362

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $1.3 billion at June 30, 2016, and $888 million at December 31, 2015, which includes a fair value derivative adjustment of $971 million and $609 million, respectively.
(2) 
Includes acquired invested assets as a result of the Chubb Corp acquisition.

Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value
The following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
June 30, 2017
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
528

 
$
85

 
$

 
$
613

 
$
602

Foreign

 
642

 

 
642

 
613

Corporate securities

 
2,688

 
12

 
2,700

 
2,645

Mortgage-backed securities

 
1,304

 

 
1,304

 
1,268

States, municipalities, and political subdivisions

 
5,301

 

 
5,301

 
5,243

Total assets
$
528

 
$
10,020

 
$
12

 
$
10,560

 
$
10,371

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,408

 
$

 
$
1,408

 
$
1,408

Short-term debt

 
931

 

 
931

 
922

Long-term debt

 
12,366

 

 
12,366

 
11,667

Trust preferred securities

 
462

 

 
462

 
308

Total liabilities
$

 
$
15,167

 
$

 
$
15,167

 
$
14,305

December 31, 2016
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
555

 
$
106

 
$

 
$
661

 
$
655

Foreign

 
667

 

 
667

 
640

Corporate securities

 
2,782

 
13

 
2,795

 
2,771

Mortgage-backed securities

 
1,428

 

 
1,428

 
1,393

States, municipalities, and political subdivisions

 
5,119

 

 
5,119

 
5,185

Total assets
$
555


$
10,102


$
13


$
10,670


$
10,644

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,403

 
$

 
$
1,403

 
$
1,403

Short-term debt

 
503

 

 
503

 
500

Long-term debt

 
12,998

 

 
12,998

 
12,610

Trust preferred securities

 
456

 

 
456

 
308

Total liabilities
$

 
$
15,360

 
$

 
$
15,360

 
$
14,821